Biotech IPO Boom Comes With Side Effects

Thu, 19 Jul 2018 00:05:14 EDT
Biotech stocks are hot tickets once again on Wall Street and that is bringing a wave of initial public offerings. The risk is the high demand for these companies is offset by a wave of new supply.

Subscribe to our newsletter

Sign up here and get the latest news and updates delivered directly to your inbox

You can unsubscribe at any time